Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25049545 |
CN |
71 | 1 |
Myelosuppression, |
||||
FRUQUINTINIB, FRUQUINTINIB, |
||||
| 502 | 25049812 |
ES |
58 | 1 |
Hepatotoxicity, Myelosuppression, |
||||
| 503 | 25050060 |
CN |
64 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, VINORELBINE, |
||||
| 504 | 25050061 |
CN |
50 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, PERTUZUMAB, |
||||
| 505 | 25051058 |
CN |
||
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 506 | 25051355 |
CN |
79 | 2 |
Myelosuppression, |
||||
CARFILZOMIB, |
||||
| 507 | 25051477 |
CN |
22 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
| 508 | 25051481 |
CN |
16 | 1 |
Myelosuppression, |
||||
IFOSFAMIDE, IFOSFAMIDE, IFOSFAMIDE, IFOSFAMIDE, IFOSFAMIDE, IFOSFAMIDE, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, |
||||
| 509 | 25051490 |
CN |
59 | 2 |
Myelosuppression, Granulocyte count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, PACLITAXEL, PACLITAXEL, |
||||
| 510 | 25051711 |
GB |
2 | |
Ascites, Myelosuppression, Weight decreased, Tachycardia, Anaemia, Constipation, Tremor, Dyspnoea exertional, Muscle atrophy, Orthostatic hypotension, Decreased appetite, Abdominal pain upper, Vomiting, Dizziness, Blood potassium decreased, Blood magnesium decreased, Asthenia, Weight decreased, Muscular weakness, Alopecia, Oedema peripheral, |
||||
LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LANSOPRAZOLE, LANSOPRAZOLE, PANCRELIPASE, PANCRELIPASE, CAPECITABINE, TEMOZOLOMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, FLUCONAZOLE, FLUCONAZOLE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITUXIMAB, CALCIUM, CALCIUM, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, OCTREOTIDE ACETATE, OCTREOTIDE, ERGOCALCIFEROL, GANCICLOVIR SODIUM, GANCICLOVIR, PHYTONADIONE, |
||||
| 511 | 25052002 |
CN |
66 | |
Oropharyngeal pain, Oral pain, Oral mucosa erosion, Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 512 | 25052046 |
US |
2 | 2 |
Leukaemia recurrent, Myelosuppression, |
||||
REVUMENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 513 | 25052132 |
CN |
62 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, CAPECITABINE, TRASTUZUMAB, |
||||
| 514 | 25052334 |
CN |
22 | 1 |
Myelosuppression, Transaminases increased, |
||||
CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 515 | 25052428 |
CN |
66 | |
Myelosuppression, Anaemia, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, PACLITAXEL, |
||||
| 516 | 25052740 |
CN |
50 | 2 |
Myelosuppression, Hypokalaemia, |
||||
TRASTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, PACLITAXEL, |
||||
| 517 | 25043427 |
CN |
68 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 518 | 25043686 |
CN |
||
Platelet count decreased, Myelosuppression, Granulocyte count decreased, |
||||
BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 519 | 25043725 |
CN |
70 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, LEUCOVORIN CALCIUM, FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 520 | 25043792 |
CN |
53 | |
Myelosuppression, |
||||
PACLITAXEL, |
||||
| 521 | 25043804 |
CN |
54 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 522 | 25043836 |
CN |
71 | |
Myelosuppression, |
||||
CISPLATIN, PEMETREXED DISODIUM, PEMETREXED, |
||||
| 523 | 25044237 |
CN |
71 | 2 |
Myelosuppression, Pyrexia, |
||||
BEVACIZUMAB, ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 524 | 25044439 |
NL |
1 | |
Osteonecrosis, Myelosuppression, |
||||
METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 525 | 25045055 |
US |
2 | |
Septic shock, Pneumonia, Folliculitis, Epistaxis, Neutropenia, Goitre, Tremor, Normocytic anaemia, Hepatitis B surface antibody positive, Myelosuppression, Pancytopenia, Drug ineffective for unapproved indication, Off label use, |
||||
PREDNISONE, PREDNISONE, ROMIPLOSTIM, FILGRASTIM, METHIMAZOLE, METHIMAZOLE, CHOLESTYRAMINE, CHOLESTYRAMINE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 526 | 25045460 |
JP |
67 | 2 |
Neuropathy peripheral, Myelosuppression, |
||||
OXALIPLATIN, BEVACIZUMAB, |
||||
| 527 | 25045507 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, CETUXIMAB, |
||||
| 528 | 25045588 |
VN |
10 | 2 |
Myelosuppression, Transplant rejection, Platelet count, Granulocyte count decreased, Megakaryocytes decreased, Hepatic enzyme increased, Off label use, |
||||
CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MELPHALAN, |
||||
| 529 | 25045918 |
MY |
||
Myelosuppression, |
||||
UPADACITINIB, |
||||
| 530 | 25045975 |
CN |
61 | 2 |
Myelosuppression, Platelet count decreased, |
||||
| 531 | 25046001 |
CN |
40 | 2 |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 532 | 25046032 |
IN |
50 | 2 |
Myelosuppression, Hypokalaemia, Fatigue, Hypomagnesaemia, Hypocalcaemia, |
||||
OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, |
||||
| 533 | 25046204 |
JP |
31 | 2 |
Myelosuppression, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, LETERMOVIR, AZATHIOPRINE, |
||||
| 534 | 25046792 |
CN |
67 | 2 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
| 535 | 25047043 |
CN |
75 | 1 |
Myelosuppression, |
||||
| 536 | 25047146 |
CN |
58 | 1 |
Myelosuppression, Intentional product use issue, |
||||
DARATUMUMAB, DARATUMUMAB, LENALIDOMIDE, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 537 | 25047186 |
CN |
62 | |
Myelosuppression, |
||||
PACLITAXEL, |
||||
| 538 | 25047201 |
JP |
71 | 2 |
Myelosuppression, Autoimmune haemolytic anaemia, Off label use, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 539 | 25047668 |
CN |
67 | 2 |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL, FLUOROURACIL, |
||||
| 540 | 25047734 |
CN |
70 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, CISPLATIN, LETROZOLE, LETROZOLE TABLETS, |
||||
| 541 | 25047992 |
CN |
56 | |
Myelosuppression, |
||||
| 542 | 25048030 |
MY |
||
Myelosuppression, |
||||
UPADACITINIB, |
||||
| 543 | 25038881 |
CN |
48 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 544 | 25039046 |
CN |
50 | |
Myelosuppression, |
||||
OSIMERTINIB, |
||||
| 545 | 25039520 |
CZ |
66 | 1 |
Myelosuppression, Neurotoxicity, Drug ineffective, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CYTARABINE, OXALIPLATIN, |
||||
| 546 | 25039909 |
CN |
57 | |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, |
||||
| 547 | 25039931 |
ES |
58 | 1 |
Hepatotoxicity, Myelosuppression, |
||||
AMOXICILLIN, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 548 | 25040013 |
CN |
49 | |
Myelosuppression, Platelet count decreased, Anaemia, |
||||
OLAPARIB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 549 | 25040028 |
CN |
43 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 550 | 25040752 |
AU |
2 | |
Drug ineffective, Myelosuppression, Thrombocytopenia, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, PREDNISONE, |
||||
| 551 | 25040766 |
CN |
50 | 2 |
Myelosuppression, Diarrhoea, Asthenia, |
||||
TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, PERTUZUMAB, |
||||
| 552 | 25041524 |
IN |
6 | 2 |
Diarrhoea, Hypokalaemia, Hypocalcaemia, Hypomagnesaemia, Myelosuppression, Pancytopenia, Leukopenia, Thrombocytopenia, Metabolic acidosis, Metabolic alkalosis, Cough, Dehydration, |
||||
OXALIPLATIN, FLUOROURACIL, |
||||
| 553 | 25042102 |
CN |
||
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL, FLUOROURACIL, |
||||
| 554 | 25042156 |
CN |
||
Myelosuppression, Thrombocytopenia, |
||||
ABEMACICLIB, |
||||
| 555 | 25042313 |
CN |
54 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 556 | 25042408 |
CN |
51 | 2 |
Myelosuppression, Gastrointestinal disorder, Fatigue, Alopecia, Anaemia, Therapy partial responder, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 557 | 25042526 |
CN |
66 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, |
||||
| 558 | 25042556 |
CN |
62 | 2 |
Myelosuppression, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, TRASTUZUMAB, |
||||
| 559 | 25042913 |
CN |
45 | 2 |
Myelosuppression, |
||||
| 560 | 25042920 |
CN |
58 | |
Myelosuppression, Off label use, |
||||
ZANUBRUTINIB, LENALIDOMIDE, |
||||
| 561 | 25042936 |
CN |
64 | 2 |
Myelosuppression, Asthenia, |
||||
ERIBULIN MESYLATE, CARBOPLATIN, |
||||
| 562 | 25042952 |
JP |
7 | 2 |
Myelosuppression, Aplasia pure red cell, Aplastic anaemia, |
||||
PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 563 | 25042966 |
CN |
64 | 1 |
Myelosuppression, |
||||
PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 564 | 25042993 |
CN |
72 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 565 | 25043000 |
JP |
7 | 2 |
Myelosuppression, Pyrexia, Platelet count decreased, Hepatic function abnormal, Neutrophil count decreased, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 566 | 25043002 |
CN |
69 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 567 | 25043118 |
US |
||
Myelosuppression, |
||||
TALQUETAMAB, |
||||
| 568 | 25043238 |
CN |
77 | 2 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, |
||||
| 569 | 25043292 |
JP |
||
Death, Acute myeloid leukaemia, Therapeutic product effect incomplete, Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 570 | 25034175 |
CN |
36 | 1 |
Granulocyte count decreased, Myelosuppression, |
||||
OBINUTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 571 | 25034479 |
CN |
75 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 572 | 25034514 |
CN |
75 | 2 |
Myelosuppression, Agranulocytosis, Pyrexia, |
||||
TRASTUZUMAB, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 573 | 25034527 |
CN |
73 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 574 | 25034557 |
CN |
35 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 575 | 25034825 |
CN |
38 | 2 |
Myelosuppression, Pyrexia, Dizziness, Asthenia, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 576 | 25035075 |
CN |
69 | 1 |
Myelosuppression, Platelet count decreased, |
||||
PRALSETINIB, PRALSETINIB, PRALSETINIB, PRALSETINIB, PRALSETINIB, |
||||
| 577 | 25035416 |
CN |
52 | 2 |
Myelosuppression, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, |
||||
| 578 | 25035572 |
CN |
56 | |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, DENOSUMAB, |
||||
| 579 | 25035588 |
CN |
58 | |
Myelosuppression, |
||||
DURVALUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 580 | 25035679 |
IN |
2 | |
Hypokalaemia, Hypocalcaemia, Hypomagnesaemia, Myelosuppression, Fatigue, |
||||
FLUOROURACIL, OXALIPLATIN, |
||||
| 581 | 25035860 |
CN |
50 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 582 | 25036023 |
CN |
||
Myelosuppression, |
||||
CAPECITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 583 | 25036361 |
CN |
67 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 584 | 25036471 |
CN |
||
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, |
||||
| 585 | 25036479 |
CN |
||
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, FULVESTRANT, DENOSUMAB, |
||||
| 586 | 25036497 |
CN |
||
Myelosuppression, |
||||
ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 587 | 25036530 |
CN |
72 | 2 |
Myelosuppression, |
||||
| 588 | 25036758 |
CN |
65 | 2 |
Myelosuppression, Cytokine release syndrome, Disease progression, Haemophagocytic lymphohistiocytosis, Deep vein thrombosis, Insomnia, Granulocyte count decreased, Pyrexia, Cystitis interstitial, |
||||
POLATUZUMAB VEDOTIN, GLOFITAMAB, |
||||
| 589 | 25036794 |
CN |
||
Myelosuppression, |
||||
CISPLATIN, PACLITAXEL, |
||||
| 590 | 25036795 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 591 | 25036796 |
CN |
||
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CISPLATIN, CISPLATIN, |
||||
| 592 | 25036839 |
CN |
56 | 1 |
Myelosuppression, |
||||
ABEMACICLIB, ABEMACICLIB, EXEMESTANE, EXEMESTANE, |
||||
| 593 | 25036845 |
CN |
65 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, EXEMESTANE, |
||||
| 594 | 25036990 |
CN |
51 | 2 |
Myelosuppression, Asthenia, Hypoaesthesia, Off label use, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, ISONIAZID, ISONIAZID, ISONIAZID, |
||||
| 595 | 25037125 |
CN |
24 | 1 |
Neoplasm malignant, Condition aggravated, Myelosuppression, White blood cell count decreased, Granulocyte count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 596 | 25037127 |
CN |
2 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TOPOTECAN, |
||||
| 597 | 25037128 |
CN |
16 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
| 598 | 25037132 |
CN |
0 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 599 | 25037235 |
CN |
26 | 2 |
Myelosuppression, Nausea, Dizziness, Abdominal distension, Pyrexia, Off label use, |
||||
CYTARABINE, AZACITIDINE, AZACITIDINE FOR, DECITABINE, FLUDARABINE PHOSPHATE, |
||||
| 600 | 25037290 |
CN |
56 | 2 |
Myelosuppression, Product use issue, |
||||
PEMBROLIZUMAB, PACLITAXEL, CISPLATIN, CISPLATIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28